- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
- Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
- Hologic Announces Financial Results for First Quarter of Fiscal 2024
More ▼
Key statistics
On Wednesday, Hologic Inc (HOLX:NSQ) closed at 76.71, -12.71% below its 52-week high of 87.88, set on May 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 76.76 |
---|---|
High | 77.38 |
Low | 76.50 |
Bid | 75.33 |
Offer | 79.36 |
Previous close | 77.19 |
Average volume | 1.52m |
---|---|
Shares outstanding | 234.73m |
Free float | 232.98m |
P/E (TTM) | 36.70 |
Market cap | 18.12bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 15 minutes, as of Apr 24 2024 21:00 BST.
More ▼